Volume : 3, Issue : 8, AUG 2017




Obesity is a growing epidemic affecting millions worldwide. It has numerous effects on various systems of the body leading to physiological changes that may cause the development of diseases like high blood pressure, heart disease, high blood cholesterol and type 2 diabetes. The impact of obesity on the skin has received minimal attention. The purpose of this article is to highlight the association between obesity and dermatologic conditions. We presented skin diseases related to mechanical injures due to obesity (plantar keratosis, stretch marks, cellulitis, lymphatic edema, chronic venous insufficiency), dermatologic diseases aggravated by obesity (psoriasis, acne vulgaris, hydradenitis suppurativa) and consequences of bariatric surgery. Moreover many studies confirmed that obesity is a risk factor for developing autoimmune disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome). Visceral fatty tissue produces adipokines (leptin, adiponectin, resistin, visfatin), which are involved in the development of autoimmune disorders. Skin lesions and disorders associated with obesity are symptoms of an increased risk of atherosclerosis and coronary artery disease too. Awareness of these disorders may help to diagnose the subclinical phase, and thus early implement the appropriate management for patients. The treatment of obesity is a difficult task and requires the action of multidisciplinary teams of physicians, dieticians, physiotherapists and psychologists. Knowledge of skin disorders and dermatological diseases in obese people is necessary because of global epidemic of obesity.


Article : Download PDF

Cite This Article

Article No : 9

Number of Downloads : 497


1. Hsu, H.S., Chen, W., Chen, S.C., et al. (1996) Colored striae in obese children and adolescents. Zhonghua Min Guo. Xiao Er Ke Yi Xue Hui Za Zhi, 37, p. 349-352. 2. Tobin, A.M., Ahern, T., Rogers, S., et al. (2013) The dermatological consequences of obesity. International Journal of Dermatology, 52, p. 927-932. 3. Yosipovitch, G., DeVore, A., and Dawn, A. (2007) Obesity and the skin: skin physiology and skin manifestations of obesity. Journal of the American Academy Dermatology, 56, p. 901-916. 4. Cordeiro, R.C., Zecchin, K.G., de Morae,s A.M. (2010) Expression of estrogen, androgen, and glucocorticoid receptors in recent striae distensae. International Journal of Dermatology, 49, p. 30–32. 5. Sami, K., Elshahat, A., Moussa, M., Abbas, A., Mahmoud, A. (2015) Image analyzer study of the skin in patients with morbid obesity and massive weight loss. Eplasty, e4. 6. Spink, M.J., Menz, H.B., Lord, S.R. (2009) Distribution and correlates of plantar hyperkeratotic lesions in older people. Journal of Foot Ankle Research, 30, p. 8. 7. Scheinfeld, N.S., Parish, D.H., Parish, L.C. (2007) A primer of skin diseases associated with obesity Expert Review of Dermatology, 2, p. 409-415. 8. Shipman, A.R. and Millington, G.W. (2011) Obesity and the skin. British Journal of Dermatology, 165, p. 743-50. 9. Kruglikov, I. (2012) The pathophysiology of cellulite: can the puzzle eventually be solved? Journal of Cosmetics, Dermatological Sciences and Applications, 2, p. 1-7. 10. de la Casa Almeida, M., Suarez Serrano, C., Rebollo Roldán, J., Jiménez Rejano, J.J. (2013) Cellulite's aetiology: a review. Journal of the European Academy of Dermatology and Venereology, 27, p. 273-278. 11. Emanuele, E. (2011) Toward a molecular understanding of cellulite: facts, controversies, and future directions. Journal of the American Academy of Dermatology, 64, p. 439. 12. Goldman, A., Gotkin, R.H., Sarnoff, D.S., et al. (2008) Cellulite: a new treatment approach combining subdermal Nd: YAG laser lipolysis and autologous fat transplantation. Aesthetic Surgery Journal, 28, p. 656-662.
13. Rodríguez, A., Catalán, V., Gómez-Ambrosi, J, et al. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Curr Pharm Des. 2007;13:2169-2175. 14. Kohli, R., Argento, V., Amoateng-Adjepong, Y. (2013) Obesity-associated abdominal elephantiasis. Case Report Medicine, 2013, p. 626739. 15. Al-Niaimi, F. and Cox, N. (2009) Cellulitis and lymphoedema: a vicious cycle. Journal of Lymphoedema, 4, p. 38-42. 16. Mortimer, P. and Levick, R. (2004) Chronic peripheral oedema: the critical role of the lymphatic system. Clin Med, 4, p. 448–453. 17. Manolopoulos, K.N., Karpe, F., Frayn, K.N. (2010) Gluteofemoral body fat as a determinant of metabolic health. International Journal of Obesity, 43, p. 949-959. 18. Danielsson, G., Eklof, B., Grandinetti, A., Kistner, R.L. (2002) The influence of obesity on chronic venous disease. Vascular Endovascular Surgery, 36, p. 271–276. 19. Iannuzzi, A., Panico, S., Ciardullo, A.V. et al. (2002) Varicose veins of the lower limbs and venous capacitance in postmenopausal women: relationship with obesity. Journal of Vascular Surgery, 36, p. 965-968. 20. Romualdi, D., Guido, M., Ciampelli, M., et al. (2003) Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome. Human Reproduction, 18, p. 1210-1218. 21. Lim, Z.V. and Oon, H.H. (2016) Management of hidradenitis suppurativa in patients with metabolic comorbidities. Annals of Dermatology, 28, p. 147-151. 22. Melnik, B.C. and Zouboulis, C.C. (2013) Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne. Experimental of Dermatology, 22, p. 311-315. 23. Alan, S. and Cenesizoglu, E. (2014) Effects of hyperandrogenism and high body mass index on acne severity in women. Saudi Medicine Journal, 35, p. 886-889. 24. Del Prete, M., Mauriello, M.C., Faggiano, A., et al. (2012) Insulin resistance and acne: a new risk factor for men? Enodcrine, 42, p. 555–560. 25. Melnik, B.C., John, S.M., Plewig, G. (2013) Acne: risk indicator for increased body mass index and insulin resistance. Acta Dermato-Venereologica, 93, p. 644-649.
26. Seleit, I., Bakry, O.A., Abdou, A.G., Hashim, A. (2014) Body mass index, selected dietary factors, and acne severity: are they related to in situ expression of insulin-like growth factor-1? Analitical and Quantitative Cytopathology and Histpathology, 36, p. 267-278. 27. Napolitano, M., Megna, M., Monfrecola, G. (2015) Insulin resistance and skin diseases. Scientific World Journal, 2015, p. 479354. 28. Kumari, R. and Thappa, D.M. (2013) Role of insulin resistance and diet in acne. Indian Journal of Dermatology, Venereology and Leprology, 79, p. 291-299. 29. Slade, D.E., Powell, B.W., Mortimer, P.S. (2003) Hidradenitis suppurativa: pathogenesis and management. British Journal of Plastic Surgery, 56, p. 451–461. 30. Miller, I.M., Rytgaard, H., Mogensen, U.B., et al. (2016) Body composition and basal metabolic rate in Hidradenitis Suppurativa: a Danish population-based and hospital-based cross-sectional study. Journal of the European Academy of Dermatology and Venereology, 30, p. 980-988. 31. Owczarczyk-Saczonek, A., Nowicki, R. (2013) Pathophysiology of the relationship of psoriasis and metabolic disorders. Przegląd Dermatologiczny, 100, p. 125-131. 32. Naldi, L., Chatenoud, L., Linder, D., et al. (2005) Cigarette smoking, Body Mass Index, and stressful life events as risk factors for psoriasis: results from an Italian case–control study. Journal of Investing Dermatolology, 125, p. 61-67. 33. Armstrong, A.W., Harskamp, C.T., Armstrong, E.J. (2012) The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutrition and Diabetes, 2, e54. 34. Gottlieb, A.B., Dann, F., Menter, A. (2008) Psoriasis and the metabolic syndrome. Journal of Drugs Dermatology, 7, p. 563-572. 35. Jin, Y., Zhang, F., Yang, S. et al. (2008) Combined effects of HLA-Cw6, body mass index and waist–hip ratio on psoriasis vulgaris in Chinese Han population. Journal of Dermatology Science, 52, p. 123-129. 36. Mercy, K.M and Paller, A.S. (2013) The relationship between obesity and psoriasis in the pediatric population: implications and future directions. Cutis, 92, p. 107-109. 37. Soltani-Arabshahi, R., Wong, B., Feng, B.J., et al. (2010) Obesity in early adulthood as a risk factor for psoriatic arthritis. Archives Dermatology, 146, p. 721-726.
38. Carrascosa, J.M., Rocamora, V., Fernandez-Torres, R M., et al. (2014) Obesity and psoriasis: inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implications. Actas Dermo-Sifiliograficas, 105, p.31-44. 39. Olszanecka-Glinianowicz, M., Zahorska-Markiewicz, B., Żurakowski, A., et al. (2005) Role of tumor necrosis factor-alfa in the control of metabolism. Wiadomości Lekarskie, 58, p. 670-674. 40. Boehncke, W.H., Boehncke, S., Tobin, A.M., Kirby, B. (2011) The “psoriatic march”: a concept of how severe psoriasis may drive cardiovascular comorbidity. Experimental Dermatology, 20, p. 303-307. 41. Gerkowicz, A., Pietrzak, A., Szepietowski, J.C., et al. (2012) Biochemical markers of psoriasis as a metabolic disease. Folia Histochemica and Cytobiologica, 50, p. 155-170. 42. Ismail, S.A. and Mohamed, S.A. (2012) Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity. British Journal of Dermatology, 167, p. 436-439. 43. Takahashi, H., Tsuji, H., Honma, M. et al. (2013) Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis. Archives Dermatology Research, 305, p. 113-116. 44. Gremese, E., Tolusso, B., Gigante, M.R., Ferraccioli, G. (2014) Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). Frontiers in Immunology, 11, p. 576. 45. Katz, P., Julian, L., Tonner, M.C., et al. (2012) Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus. Arthritis Care and Research (Hoboken), 64, p. 502-510. 46. Versini, M., Jeandel, P.Y., Rosenthal, E., Shoenfeld, Y. (2014) Obesity in autoimmune diseases: not a passive bystander. Autoimmunity Reviews, 13, p. 981-1000. 47. Chaiamnuay, S., Bertoli, A.M., Roseman, J.M., et al. (2007) African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV). Annals of Rheumatic Diseases, 66, p. 618-622. 48. Nikpour, M., Urowitz, M.B., Gladman, D.D. (2009) Epidemiology of atherosclerosis in systemic lupus erythematosus. Current Rheumatology Reports, 11, p. 248–254.
49. Rizk, A., Gheita, T.A., Nassef, S., Abdallah, A. (2012) The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis. International Journal of Rheumatology Diseases, 15, p. 261-267. 50. Procaccini, C., Carbone, F., Galgani, M., et al. (2011) Obesity and susceptibility to autoimmune diseases. Expert Review of Clinical Immunology, 7, 287-294. 51. Versini, M., Aljadeff, G., Jeandel, P.Y., Shoenfeld, Y. (2014) Obesity: an additional piece in the mosaic of autoimmunity. Israel Medical Associacion Journal, 16, p. 619-621. 52. Winer, S., Paltser, G., Chan, Y., et al. (2009) Obesity predisposes to Th17 bias. European Journal of Immunology, 39, 2629-2635. 53. Sumarac-Dumanovic, M., Stevanovic, D., Ljubic, A., et al. (2009) Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. International Journal of Obese, 33, p. 151-156. 54. Arai, S. and Miyazaki, T. (2014) Impacts of the apoptosis inhibitor of macrophage (AIM) on obesity-associated inflammatory diseases. Seminars in Immunopathology, 36, p. 3-12. 55. de Giorgi, V., Gori, A., Grazzini, M., et al. (2012) Obesity and melanoma. British Journal of Dermatology, 166, p. 1357-1358; author reply 1358-1359. 56. Brandon, E.L., Gu, J.W., Cantwell, L., et al. (2009) Obesity promotes melanoma tumor growth: role of leptin. Cancer Biology and Therapy, 8, p. 1871–1879. 57. Renehan, A.G., Tyson, M., Egger, M., et al. (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 371, p. 569–578. 58. Millington, G.W. (2013) Obesity, genetics and the skin. Clinical and Experimental Journal of Dermatology, 38, p. 50-56; 59. Skowron, F., Bérard, F., Balme, B., Maucort-Boulch, D. (2015) Role of obesity on the thickness of primary cutaneous melanoma. Journal of European Academy of Dermatology and Venereology, 29, p. 262-269. 60. Olsen, C.M., Hughes, M.C., Pandeya, N., Green, A.C. (2012) Anthropometric measures in relation to basal cell carcinoma: a longitudinal study. BMC Cancer, 27, p. 82. 61. Pothiawala, S., Qureshi, A.A., Li, Y., Han, J. (2012) Obesity and the incidence of skin cancer in US Caucasians. Cancer Causes Control, 23, 717-726.
62. Wollina, U., Dreßler, M., Lohmann, T. (2015) Bariatric surgery - a dermatologic perspective. Journal of European Academy of Dermatology and Venereology, 29, p. 835-841. 63. Kromann, C., Ibler, K.S., Kristiansen, V., Jemec, G.B. (2014) The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Dermato- Venereologica, 94, p. 553–557. 64. Hossler, E.W., Wood, G.C., Still, C.D., et al. (2013) The effect of weight loss surgery on the severity of psoriasis. British Journal of Dermatology, 168, p. 660-661. 65. Rojas, P., Gosch, M., Basfi-fer, K., et al. (2011) Alopecia in women with severe and morbid obesity who undergo bariatric surgery. Nutricion Hospitalaria, 26, p. 856-862. 66. da Silva, P.R., de Souza, M.R., da Silva, E.M., da Silva, S.A. (2014) Nutritional status and life quality in patients undergoing bariatric surgery. Arquivos Brasileiros Cirurgia Digestiva, 27, p. 35-38. 67. Cañas, C.A., Echeverri, A.F., Ospina, F.E., et al. (2016) Is bariatric surgery a trigger factor for systemic autoimmune diseases? Journal of Clinical Rheumatology, 22, p. 89-91. 68. Manzoni, A.P. and Weber, M.B. (2015) Skin changes after bariatric surgery. Anais Brasileiros de Dermatologia, 90, 157-166. 69. Dwivedi, S. and Jhamb, R. (2010) Cutaneous markers of coronary artery disease. World Journal of Cardiology, 2, p. 262-269.